Protected by an international patent, ERYtech Pharma's innovative technology makes it possible to produce, on an industrial scale, a constant quality of erythrocytes loaded with drugs – at a constant incorporation rate and at a constant cell rate – whatever their initial characteristics are and whether they come from patients or not.

ERYtech Pharma’s technological process is innovative, performant, reproducible and safe.

It enables to fully control all parameters – such as red blood cells quality, time of process, size of the molecule to be encapsulated, process temperature – throughout the process which is only two hours long.

An ERYcaps machine is functional at the Cell Therapy Unit of the anticancer Centre Léon Bérard (Lyon) where clinical batches are produced.